Erschienen in:
01.08.2019 | Images that Teach
Can 99mTc-labeled RBC-equilibrium radionuclide angiocardiography be an adjunct imaging biomarker for marrow hyperplasia in beta-thalassemia major patients?
verfasst von:
Shelvin Kumar Vadi, MD, Sonia Kashyap, MBBS, Ashwani Sood, DNB, Alka Khadwal, DM, MD, Madan Parmar, MSc, Ashwin Singh Parihar, MBBS, Bhagwant Rai Mittal, MD, DNB
Erschienen in:
Journal of Nuclear Cardiology
|
Ausgabe 4/2019
Einloggen, um Zugang zu erhalten
Excerpt
Beta-thalassemia major (TM) is a hereditary disorder characterized by ineffective erythropoiesis owing to anomalies in beta-chain of hemoglobin and the peripheral anemia results in ineffective expansion and hyperplasia of the bone marrow.
1 These patients require multiple tests to monitor the adequacy of blood transfusion and iron overload.
299mTc-labeled red blood cell-equilibrium radionuclide angiocardiography (
99mTc RBC-ERNA) in these patients is used for monitoring of left ventricular ejection function (LVEF), along with prospect for whole-body marrow imaging as an indicator for adequacy of transfusion. …